The prefilled syringe drug molecule market is set for significant expansion, with projected sales increasing from USD ...

Azurity Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved Danziten™, the first and only nilotinib with no mealtime restrictions indicated for adult patients ...